Trial Profile
Target site pharmacokinetics of linezolid after repetitive doses in diabetic patients with bacterial foot infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Bacterial infections; Osteomyelitis; Soft tissue infections
- Focus Pharmacokinetics
- 05 Nov 2016 Status changed from recruiting to completed.
- 04 Jul 2012 Company added in the association field as reported by EudraCT.
- 27 Jul 2011 New trial record